A61K 31/429
Condensed with heterocyclic ring systems
Official title: condensed with heterocyclic ring systems
A61K31/429 (Condensed with heterocyclic ring systems) appears on 1,223 US grants and 1,848 published applications in this corpus.
Search patents in A61K- Granted patents
- 1,223
- Published applications
- 1,848
- Assignees
- 953
- Inventors
- 4,067
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 18 | 0 |
| 1977 | 7 | 0 |
| 1978 | 12 | 0 |
| 1979 | 5 | 0 |
| 1980 | 8 | 0 |
| 1981 | 14 | 0 |
| 1982 | 7 | 0 |
| 1983 | 12 | 0 |
| 1984 | 18 | 0 |
| 1985 | 26 | 0 |
| 1986 | 5 | 0 |
| 1987 | 8 | 0 |
| 1988 | 5 | 0 |
| 1989 | 6 | 0 |
| 1990 | 8 | 0 |
| 1991 | 7 | 0 |
| 1992 | 4 | 0 |
| 1993 | 6 | 0 |
| 1994 | 1 | 0 |
| 1995 | 8 | 0 |
| 1996 | 3 | 0 |
| 1997 | 18 | 0 |
| 1998 | 11 | 0 |
| 1999 | 15 | 0 |
| 2000 | 17 | 0 |
| 2001 | 17 | 8 |
| 2002 | 26 | 37 |
| 2003 | 28 | 42 |
| 2004 | 15 | 59 |
| 2005 | 12 | 42 |
| 2006 | 16 | 52 |
| 2007 | 21 | 48 |
| 2008 | 10 | 47 |
| 2009 | 11 | 49 |
| 2010 | 28 | 54 |
| 2011 | 21 | 70 |
| 2012 | 38 | 48 |
| 2013 | 39 | 65 |
| 2014 | 47 | 121 |
| 2015 | 48 | 98 |
| 2016 | 64 | 123 |
| 2017 | 75 | 91 |
| 2018 | 58 | 97 |
| 2019 | 59 | 102 |
| 2020 | 66 | 98 |
| 2021 | 66 | 113 |
| 2022 | 45 | 81 |
| 2023 | 49 | 81 |
| 2024 | 48 | 84 |
| 2025 | 39 | 81 |
| 2026 | 28 | 57 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Medication that protects the intestinal microbiota and their preparation methods and applications6 Oct 2026US 12,751,921 B2University of Science and Technology of China
- TEAD inhibitors29 Sep 2026US 12,747,207 B2Orion Corporation
- Short conjugated oligoelectrolytesand antibiotics22 Sep 2026US 12,740,950 B2Nanyang Technological University
- Compounds for the treatment of bacterial infections and potentiation of antibiotics8 Sep 2026US 12,728,105 B2Georgia State University Research Foundation, Inc.
- Use of membrane inhibitors to enhance vaccine development against enveloped viruses8 Sep 2026US 12,728,161 B2Cornell University
- Combination therapy for bacterial infections comprising zinc-chelator, beta-lactam antibiotic and serine beta-lactamase inhibitor8 Oct 2026US 2026/0306526 A1Adjutec Pharma AS
- Biarylamide derivatives and their use as pkmyt1 inhibitors1 Oct 2026US 2026/0297042 A1Cancer Research Technology Limited
- Cyclic vinyl sulfone wrn inhibitors1 Oct 2026US 2026/0297070 A1Nimbus Wadjet, Inc.
- Tp0751 chimera-containing vaccine1 Oct 2026US 2026/0297141 A1University of Washington
- Compounds for restoring susceptibility to beta-lactam antibiotics24 Sep 2026US 2026/0284011 A1University of Notre Dame du Lac
Most cited
By later US patents
- Pharmaceutical and cosmetic carrier or composition for topical application284US 6,911,211 B2Foamix Ltd. · 2005
- Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth243US 6,861,053 B1Cedars-Sinai Medical Center · 2005
- Probiotic recolonisation therapy240US 8,460,648 B22013
- Method for treatment of idiopathic inflammatory bowel disease (IIBD)229US 5,599,795 A1997
- Pharmaceutical formulations for parenteral use208US 5,024,998 AUniversity of Florida · 1991